Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
In the Senate - First Reading Senate Rules
Summary
The bill lets the Maryland State Board of Pharmacy issue permits for pharmacies that only serve clinical research trials. It permits doctors, nurses or other licensed providers to hold an ownership stake in such pharmacies if a licensed pharmacist is on‑site and referral fees are prohibited. The change also removes experimental treatments from the legal definition of “practice of medicine,” so they don’t trigger usual licensing requirements.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 1426 changes status, plus AI-powered summaries and stage predictions.
Sign up free